Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors

Details Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors

2003-11-10

2009-02-10

Wilson, James O. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C544S287000, C544S119000, C544S313000, C514S266200, C514S266400, C546S160000, C546S162000

Reexamination Certificate

active

07488823

ABSTRACT:
Cyanoguanidine quinazoline and cyanoamidine quinazolamine derivatives that are useful in the treatment of hyperproliferative diseases are disclosed. Methods of treating hyperproliferative diseases in mammals are also disclosed.

REFERENCES:
patent: 5112817 (1992-05-01), Fukazawa et al.
patent: 5204348 (1993-04-01), Fukazawa et al.
patent: 5405843 (1995-04-01), Fukazawa et al.
patent: 5821246 (1998-10-01), Brown
patent: 5955464 (1999-09-01), Barker
patent: 6127374 (2000-10-01), Bridges
patent: 6184225 (2001-02-01), Thomas et al.
patent: 6225318 (2001-05-01), Sobolov-Jaynes et al.
patent: 6391874 (2002-05-01), Cockerill et al.
patent: 7081461 (2006-07-01), Mortlock et al.
patent: 2002/0042409 (2002-04-01), Luzzio et al.
patent: 2002/0169165 (2002-11-01), Kath et al.
patent: 2004/0242604 (2004-12-01), Bhattacharya et al.
patent: 2005/0043334 (2005-02-01), Wallace et al.
patent: 2005/0043336 (2005-02-01), Hennequin et al.
patent: 2005/0049419 (2005-03-01), Wallace et al.
patent: 2005/0054701 (2005-03-01), Wallace et al.
patent: 2005/0130943 (2005-06-01), Wallace et al.
patent: 2005/0153942 (2005-07-01), Wallace et al.
patent: 2005/0250782 (2005-11-01), Marlow et al.
patent: WO 96/09294 (1996-03-01), None
Supplementary European Search Report, issued in Corresponding European Patent Application No. 03768789.4-1211, dated on May 21, 2007.

Affiliated with

Also associated with

Rating

Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4097518